Camcevi Injection, Emulsion
Product Images NDC 69448-014

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Camcevi (NDC 69448-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Biopharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel -blister Label (Camcevi Inj Blister Label)

CAMCEVI 42 mg injectable emulsion in a single-dose pre-filled syringe, containing leuprolide. This packaging label identifies the product as a subcutaneous injection by Accord BioPharma, Inc. It includes storage instructions, administration guidelines, and details the syringe and needle contents in a blister carton. Manufactured in France.*

FDA Label Image

Principal Display Panel -carton Label (back) (Camcevi Inj Carton Label 1)

Illustrated instructions for syringe assembly, injection site preparation, treatment administration, and needle protection for CAMCEVI 42 mg subcutaneous injection. The images and text guide users through removing contents, attaching the needle cartridge to the syringe, selecting and preparing the injection site, injecting at a 90° angle, and safely using the Point-Lok needle protection device after injection.*

FDA Label Image

Principal Display Panel -carton Label(front) (Camcevi Inj Carton Label)

Packaging label for CAMCEVI 42 mg injectable emulsion, a single-dose pre-filled syringe of leuprolide for subcutaneous injection. The label highlights it as a single-dose administration kit with pre-filled sterile syringe, manufactured by Accord BioPharma, Inc. The label includes product NDC 69448-014-63 and storage instructions.*

FDA Label Image

Camcevi-inj-figure (Camcevi Inj Figure 1)

A line graph depicting the serum testosterone percent change over time in days, with values plotted from day 0 to day 336. The curve shows a sharp initial increase followed by a steep decline to nearly -100% change, which then remains stable through the remaining days. The x-axis is labeled as Days with corresponding sample sizes below, and the y-axis as Serum Testosterone Percent Change (%).*

FDA Label Image

Camcevi-inj-image-1 (Camcevi Inj Image 1)

The image shows a three-part instructional illustration for assembling a pre-filled syringe. The first panel shows components labeled A (a syringe) and B (a needle covered by a cap). The second panel depicts hands joining the needle (B) to the syringe (A) by twisting. The third panel labels parts of the fully assembled pre-filled syringe, including Needle and Cover, End Stopper, Product, Barrel, Backstop, and Plunger Rod, along with a separate depiction of the Point-Lok needle cover.*

FDA Label Image

Camcevi-inj-image-10 (Camcevi Inj Image 10)

An instructional illustration showing a hand holding a syringe perpendicular at a 90-degree angle to the skin for subcutaneous injection. A droplet is visible at the needle tip, indicating preparation or injection process.*

FDA Label Image

Camcevi-inj-image-11 (Camcevi Inj Image 11)

An instructional diagram consisting of two steps illustrating the preparation or administration of CAMCEVI (leuprolide) injection, emulsion. The first step shows a syringe being inserted downward into a vial or container, followed by the second step showing the syringe pushed further down into the vial. The illustration is black and white line art.*

FDA Label Image

Camcevi-inj-image-2 (Camcevi Inj Image 2)

Instructional illustration showing the preparation and administration of CAMCEVI injection. The first image depicts preparing the subcutaneous injection site, and the second demonstrates inserting the needle at a 90-degree angle for treatment administration.*

FDA Label Image

Camcevi-inj-image-3 (Camcevi Inj Image 3)

An instructional illustration showing two steps for preparing an injection. Step 1 depicts pressing a syringe downward into a vial. Step 2 shows continuing to press the syringe further into the vial. The illustration uses simple line art and numbered arrows to guide the user through the process.*

FDA Label Image

Camcevi-inj-image-4 (Camcevi Inj Image 4)

CAMCEVI 42 mg injectable emulsion in a single-dose prefilled syringe. The label highlights leuprolide as the active ingredient and is presented in a bold orange and gray color scheme. The product is a subcutaneous injection manufactured by Accord BioPharma, Inc.*

FDA Label Image

Camcevi-inj-image-5 (Camcevi Inj Image 5)

An instructional illustration showing two components labeled A and B, which appear to be parts of an injection device, alongside a separate depiction of a Point-Lok® needle accessory. The parts likely relate to the subcutaneous injection assembly of CAMCEVI (leuprolide) injection, emulsion, 42 mg/.37g by Accord BioPharma, Inc.*

FDA Label Image

Camcevi-inj-image-6 (Camcevi Inj Image 6)

An instructional illustration showing two medical devices labeled A and B. Device A is a larger syringe-like injector with a plunger, and device B is a smaller injector with a blue cap, likely indicating stepwise use or assembly for subcutaneous injection administration.*

FDA Label Image

Camcevi-inj-image-7 (Camcevi Inj Image 7)

An instructional diagram illustrating the connection process of two injection components, labeled A and B, possibly demonstrating the preparation or assembly of a subcutaneous injection device for CAMCEVI (leuprolide) emulsion.*

FDA Label Image

Camcevi-inj-image-8 (Camcevi Inj Image 8)

An instructional diagram of a subcutaneous injection syringe assembly for CAMCEVI (leuprolide) showing labeled parts including the Needle and Cover, Product area within the Barrel, End Stopper, Backstop, Plunger Rod, and the Point-Lok needle hub.*

FDA Label Image

Camcevi-inj-image-9 (Camcevi Inj Image 9)

An illustration showing a hand pinching the skin, likely depicting a subcutaneous injection technique. The partial outline of a torso or abdomen is visible, with a drop near the pinched skin, indicating the injection site.*

FDA Label Image

Camcevi-inj-structure (Camcevi Inj Structure)

Chemical structure of leuprolide, the active ingredient in CAMCEVI injection, emulsion. The diagram shows the molecular arrangement including bonds and functional groups typical of the compound, with notation indicating the variable number of CH3SO3H units.*

FDA Label Image

Principal Display Panel -syringe Label (Syringe Label)

Label for CAMCEVI (leuprolide) injectable emulsion, 42 mg single-dose pre-filled syringe for subcutaneous injection only. Label shows product NDC 69448-014-63 and indicates Rx only. Manufactured by Accord BioPharma, Inc., Durham, NC. The label includes a barcode and advises to see prescribing information for dosage.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.